Moreover, as previously mentioned, TLR4 activation and high overexpression of the TLR4 gene are associated with CCA progression and worse disease outcomes, whereas lower TLR4 levels were associated with less tumor growth [29,68,84]. This evidence concerns the gene TLR4 and cholangiocarcinoma.